Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer

BACKGROUND: Targeting regulatory T cell (Treg) infiltration is an emerging strategy for cancer immunotherapy. However, its efficacy in advanced prostate cancer remains unclear. Here, we showed the therapeutic efficacy of anti-Treg treatment in a canine model of advanced prostate cancer. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Shingo, Motegi, Tomoki, Iio, Aki, Kaji, Kenjiro, Goto-Koshino, Yuko, Eto, Shotaro, Ikeda, Namiko, Nakagawa, Takayuki, Nishimura, Ryohei, Yonezawa, Tomohiro, Momoi, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804701/
https://www.ncbi.nlm.nih.gov/pubmed/35131860
http://dx.doi.org/10.1136/jitc-2021-003731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804701/
https://www.ncbi.nlm.nih.gov/pubmed/35131860
http://dx.doi.org/10.1136/jitc-2021-003731

Ejemplares similares